Workflow
江中药业: 江中药业监事会关于公司第二期限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见.docx
600750JZYY(600750) 证券之星· Zheng Quan Zhi Xing·2025-05-09 11:12

Group 1 - The core viewpoint of the article is that Jiangzhong Pharmaceutical Co., Ltd. has publicly announced the list of individuals who will be granted restricted stock under its second phase incentive plan, confirming that the selection process complies with relevant regulations and guidelines [1][3]. - The company conducted an internal public notice from April 29, 2025, to May 8, 2025, regarding the names and positions of 168 individuals selected as incentive recipients, with no objections raised during the public notice period [1]. - The supervisory board of the company has verified that the selected incentive recipients meet the eligibility criteria set forth in the relevant laws, regulations, and the company's incentive plan, confirming that there are no disqualifying circumstances [3]. Group 2 - The supervisory board concluded that the individuals listed as incentive recipients are legally and effectively qualified to receive restricted stock, adhering to the conditions outlined in the guiding documents and the company's articles of association [3]. - The incentive recipients do not include independent directors, supervisors, or shareholders holding more than 5% of the company's shares, ensuring compliance with the regulations [3]. - The announcement serves to affirm the legitimacy of the incentive plan's implementation and the qualifications of the selected individuals [1][3].